Thomas Stankovich - Nov 2, 2021 Form 4 Insider Report for ReShape Lifesciences Inc. (RSLS)

Role
Chief Financial Officer
Signature
/s/ Thomas Stankovich
Stock symbol
RSLS
Transactions as of
Nov 2, 2021
Transactions value $
-$11,621
Form type
4
Date filed
11/16/2021, 03:14 PM
Previous filing
Oct 12, 2021
Next filing
Nov 18, 2021

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction RSLS Common Stock, $0.001 par value per share Sale -$11.6K -4.32K -1.22% $2.69 350K Nov 2, 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 (1) These shares were sold to cover taxes in connection with the vesting of restricted stock units.